Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Population cancer screening

A I Sutnick, D G Miller, B Samson

    Cancer
    |September 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Implementing post-normal science with or for EU policy actors: using quantitative story-telling.

    Sustainability science·2023
    Same author

    Children and screens: Groupe de Pédiatrie Générale (Société française de pédiatrie) guidelines for pediatricians and families.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018
    Same author

    Hemoglobin levels and step test performance of men and women in Nepal.

    American journal of human biology : the official journal of the Human Biology Council·2017
    Same author

    Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016.

    Current oncology (Toronto, Ont.)·2017
    Same author

    Corrigendum: Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.

    Current oncology (Toronto, Ont.)·2016
    Same author

    Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers.

    Current oncology (Toronto, Ont.)·2016
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    A new cancer detection program, CANSCREEN, uses questionnaires and non-physician examiners for cost-effective screening. A randomized trial will assess its effectiveness and efficiency in cancer detection.

    Area of Science:

    • Oncology
    • Preventive Medicine
    • Health Services Research

    Background:

    • Controlled trials for mass cancer screening are lacking due to high costs, limited medical personnel, and low yield.
    • Existing cancer detection methods face challenges in cost-effectiveness and scalability.

    Purpose of the Study:

    • To introduce and evaluate a novel, cost-effective cancer detection program called CANSCREEN.
    • To assess the effectiveness and efficiency of a new screening approach combining questionnaires and examinations.

    Main Methods:

    • Development of the CANSCREEN program by The Fox Chase Cancer Center and Preventive Medicine Institute.
    • Utilizing a self-administered questionnaire for medical history, symptoms, and risk factors.
    • Employing non-physician examiners and a risk-factor analysis with decision logic for tailored examinations.

    Related Experiment Videos

  • Designing a randomized controlled trial to evaluate the questionnaire alone and in combination with examination.

    • Main Results:

    • The CANSCREEN program integrates a questionnaire, non-physician examiners, risk-factor analysis, and health education for improved cost-effectiveness.
    • A shared database facilitates program evaluation and the assessment of new techniques.
    • A randomized controlled trial is underway to determine the effectiveness and efficiency of the CANSCREEN components.

    Conclusions:

    • The collaborative CANSCREEN program demonstrates the feasibility of implementing cost-effective cancer screening initiatives.
    • This model, involving inter-institutional collaboration and shared data, can be replicated in other settings.
    • Further evaluation through a randomized controlled trial is crucial to validate the program's impact on cancer detection.